All stock lists
Vogenx, Inc. (VOGX)
NASDAQ: VOGX · Real-Time Price · USD
Healthcare · Biotechnology
16.25-1.20 (-6.88%)
Insider Score
––Not scored
VOGX Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
VOGX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| SG&A Expense | 198.60 K | 225.24 K | 174.27 K | 202.89 K |
| R&D Expense | 156.79 K | 237.91 K | 136.39 K | 169.31 K |
| Operating Expenses | 355.38 K | 463.15 K | 310.66 K | 372.20 K |
| Operating Income | -355.38 K | -463.15 K | -310.66 K | -372.20 K |
| Pretax Income | -384.43 K | -475.45 K | -294.80 K | -356.62 K |
| Tax Provision | — | — | — | — |
| Net Income | -384.43 K | -475.45 K | -294.80 K | -356.62 K |
| EPS (Basic) | -0.03 | — | -0.04 | -0.05 |
| EPS (Diluted) | -0.03 | — | -0.04 | -0.05 |
| Shares Outstanding | 13.91 M | 7.67 M | 7.67 M | 7.67 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.